March 5, 2015

CHPA announced its strong support for the Restoring Access to Medicines Act of 2015 (H.R. 1270).

March 4, 2015

In a meeting with nearly two dozen leaders representing consumers, insurers, providers and business leaders, Health and Human Services Secretary Sylvia Burwell on Jan. 26 announced measurable goals and a timeline to move the Medicare program, and the healthcare system at large, toward paying providers based on the quality of care they give patients.

March 4, 2015

The introduction in January of bipartisan legislation that would grant retail pharmacists provider status for Medicare patients in “underserved” communities certainly sounds like a step in the right direction.

March 2, 2015

The implementation of an e-prescribing mandate in New York hits a snag as state legislators agree to a delay.

March 2, 2015

The FDA is expected to issue new guidance on biosimilars labeling and generic opioids before the end of year, according to a report by the Regulatory Affairs Professional Society.

February 27, 2015

ACIP on Thursday recommended that children ages 6 months and older get an annual influenza vaccine with no preference stated for either the nasal spray vaccine or the flu shot.

February 26, 2015

The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.

February 26, 2015

Congress introdues legislation to protect FDA user fees from sequestration. 

February 26, 2015

The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration. 

February 26, 2015

The National Association of Chain Drug Stores has submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health expressing concerns about pharmacy-related budget proposals.

February 26, 2015

Sanofi expands its portfolio of insulin therapy products with the introduction of the once-daily, long-acting Toujeo. 

February 24, 2015

The Food and Drug Administration is looking into enabling holders of abbreviated new drug applications to unilaterally update their generic drug product labels prior to any branded drug change. 

February 24, 2015

Lupin will bring to market a generic version of Lumigan solution, the company announced. 

February 24, 2015

NPA  renewed its call to the New York Attorney General to produce the scientific evidence behind that office's recall request of herbal supplements.

February 23, 2015

Kim Coalter, a staffer for Rep. Thad Cochran, R-Miss., toured Fred's Super Dollar pharmacy in Mississippi last week.

February 20, 2015

The recently introduced Ensuring Patient Access and Effective Drug Enforcement Act of 2015 receives support from the National Association of Chain Drug Stores.

February 19, 2015

CRN files second amicus brief challenging FTC "rigid standard" in evaluating supplement claims.

February 19, 2015

Proposed New York legislation could mean big changes for some beauty brands.

February 17, 2015

The Food and Drug Administration has approved Lenvima (lenvatinib) for the treatment of differentiated thyroid cancer. 

February 13, 2015

In response to the New York Attorney General’s recent recall of herbal supplements from four major retailers, the Council for Responsible Nutrition has assembled a microsite for consumers.

February 12, 2015

Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., on Thursday introduced companion legislation to House bill H.R. 471.

 

February 12, 2015

The House Energy and Commerce Committee passed legislation to help curb prescription drug diversion and abuse and protect patients in need of medication.

February 10, 2015

GNC on Monday announced that it refuted the claims made by the New York State Attorney General in his Feb. 2 letter.

February 9, 2015

Under new bipartisan legislation, seniors would have more convenient access to discounted or "preferred" co-pays for prescription drugs at their pharmacy of choice.